Dr. Daniel Kraft M.D.

Daniel Kraft, MD, is a Stanford- and Harvard-trained physician-scientist, inventor, and investor who has spent more than 25 years at the intersection of clinical medicine, biomedical research, and emerging technology. His work explores how artificial intelligence, continuous data, and converging technologies are reshaping prevention, diagnosis, therapy, and the delivery of care, and, through his Now, Near and Next framework, what leaders, clinicians, and patients can do about it now rather than someday.

He is Founder and Chair of NextMed.Health (which began as Exponential Medicine at Singularity University), a program and community convening clinicians, technologists, investors, and regulators around the future of medicine, and Founder of Digital.Health, a curated platform for discovering and evaluating digital health and AI solutions. He is Co-Founder and General Partner at Continuum Health Ventures, backing early-stage companies working to democratize health and extend healthspan, and serves as an Adjunct Professor of Medicine at Stanford University School of Medicine. He serves on the boards of Healthy.io and Immunis Biomedical, and was founding faculty at Singularity University, where he chaired its medicine program. He served as chair of the XPRIZE Pandemic & Health Alliance.

Following undergraduate studies at Brown University and medical school at Stanford, Daniel was board certified in both internal medicine and pediatrics after a Harvard residency at Massachusetts General Hospital and Boston Children’s Hospital, and completed fellowships in hematology, oncology, and bone marrow transplantation at Stanford. His laboratory research in stem cell biology, cancer immunotherapy, and bioengineered T-cell differentiation was published in Nature and Science. He is the founder of RegenMed Systems and the inventor of its FDA-cleared MarrowMiner, a device for minimally invasive bone marrow harvest, and holds patents spanning medical devices, immunology, and stem cell therapies.

A six-time TED and TEDMED speaker who has keynoted on five continents, Daniel advises biopharma boards and executive teams, health systems, and startups on AI and digital health strategy. He wrote the lead article for National Geographic’s special issue on the future of medicine, and his work has been featured by CNN and WIRED, most recently appearing on NewsNation’s The Future is Now town hall alongside Neil deGrasse Tyson and Scott Galloway. He is a member of the inaugural class of the Aspen Institute Health Innovators Fellowship and of the Kauffman Fellows Society. He is an active pilot, served as an officer and flight surgeon with F-15 and F-16 fighter squadrons in the Massachusetts and California Air National Guard, and was a finalist for NASA astronaut selection.

Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and is member of the Kaufman Fellows Society.  

He is often called upon to speak to the future of health, medicine and technology and has given four TED and two TEDMED Talks and has delivered keynotes to a diverse array of organizations.  

He has multiple scientific publications (including in Nature and Science) and medical device, immunology, and stem cell-related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.  

Daniel's academic research has focused on: stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. His research has been published in journals that include Nature and Science. His clinical work has focused on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine, including marrow derived stem cell harvesting, processing and delivery. 

He is heavily involved in digital health, founded Digital.Health, and is on the board of Healthy.io and advises several Fortune-50 and digital health-related startups.  Daniel recently founded IntelliMedicine, focused on personalized, data-driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. 

Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.

AWARDS & RECOGNITION

• 5 Futurists to Watch in Uncertain Times (Forbes, 2023)
• The Most Influential Voices in Healthcare for 2022 (Medika Life)
• 40 of the Smartest People in Healthcare
• The Top-10 Internet Smart Doctors in the World 
• Pharma Voice 100: Annual list recognizes the most inspiring leaders in Life Sciences, as determined by their readers.
• Digital Health Top-50 (2016)
• NIH K-08 Physician-Scientist Award
• NIH SBIR Phase I / Phase II Award
• HHMI Continuing Studies Scholarship